AEON
AEON Biopharma, Inc.
There isn't enough reported data to score AEON yet.
AEON Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
AEON's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
AEON PE Valuation
AEON has no meaningful PE right now: it lost money over the past year.
AEON Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Moderate |
Analysts expect AEON's losses to shrink, with revenue holding steady.
AEON Earnings Per Share
AEON Quarterly Revenue
AEON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$4.7M | -$4.1M |
| Q3 2025 | -$2.6M | +$359K |
| Q2 2025 | -$2.1M | +$6M |
| Q1 2025 | -$7.9M | +$687K |
| Q3 2024 | -$3M | +$12.1M |
AEON has burned cash in almost every quarter: −$17M over the past year, against −$20M the year before.
AEON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +9.9M shares |
| 1 year | +1168% | +46.5M shares |
AEON has 51M diluted shares, up 1168% from a year ago.
AEON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | 0.2x | Very low |
AEON's net debt is less than a year of its operating earnings (EBITDA).
AEON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 22.6 | Neutral |
AEON's weekly RSI is 33 (neutral) and its Stochastic is 23 (neutral).
AEON PE vs Healthcare Sector
| Metric | AEON | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
AEON has no meaningful PE right now: it lost money over the past year.
AEON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.24 | 33% below |
| 20 week MA | $0.29 | 45% below |
| 50 week MA | $0.69 | 77% below |
| 100 week MA | $2.65 | 94% below |
AEON is in a downtrend: it's below all four of its weekly moving averages, and 94% below its 100-week average.
AEON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $468.0 | $518.4 | +11% |
| 2024 | $518.4 | $42.5 | -92% |
| 2025 | $42.5 | $1.02 | -98% |
| 2026 YTD | $1.02 | $0.16 | -84% |
AEON has finished lower in two of the last three years. It's down 84% so far in 2026.